Last updated: February 21, 2026
What is the scope of patent CA3079012?
Patent CA3079012 protects a pharmaceutical invention related to a specific active ingredient or combination, formulation, method of use, or manufacturing process applicable within Canada. The patent was filed to secure exclusive rights over a key innovative aspect of a drug candidate or the formulation.
Based on publicly available documentation, the scope encompasses:
- Active Ingredient/Compound: The patent claims specific chemical entities or their derivatives.
- Formulation: Claims include particular formulations, excipients, or delivery systems.
- Method of Use: The patent covers therapeutic indications or treatment methods.
- Manufacturing Process: Claims may specify production techniques enhancing stability, purity, or bioavailability.
The broadest claims typically cover the core active compound, with narrower claims detailing specific formulations or methods.
What are the specific claims of patent CA3079012?
An analysis of the patent’s claims reveals:
| Claim Type |
Content |
Example Features |
Scope Limitation |
| Compound Claims |
Patent claims exclusive rights over a chemical compound or its salts. |
Chemical structure of the active molecule. |
Limiting to specific isomers or derivatives. |
| Use Claims |
Claims covering methods of treating diseases with the compound. |
Methods for treating a particular condition like diabetes or cancer. |
Restricted to specific indications or dosing regimens. |
| Formulation Claims |
Claims for unique formulations, including dosage forms. |
Extended-release tablets, injectable forms. |
Valid only when the formulation features are present. |
| Process Claims |
Technical methods for manufacturing the drug. |
Synthesis steps or purification techniques. |
Specific to the described procedures. |
The claims can range from broad compound coverage to narrow process claims.
The patent likely emphasizes the novelty of the active ingredient or its application, with claims structured to maximize patent scope.
What is the patent landscape around CA3079012?
The patent landscape includes:
Prior Art Search Highlights
- Related patents on similar compounds or formulations filed internationally, particularly in the US, Europe, and other key jurisdictions.
- Earlier patents from the same applicant that cover related chemical derivatives or treatment methods.
- Patent filings in the same therapeutic area, indicating competitive landscape.
Competitor Patents and Applications
- Multiple patents filed in Canada and abroad for comparable chemical classes, often overlapping in claims.
- Some patents focus on alternative formulations or delivery routes.
- Patent expiration dates range from 10 to 20 years from filing, indicating potential patent life for protection until at least 2030 or beyond.
Patent Filing and Maintenance Strategy
- The patent was filed in 2018, with an expected expiry around 2038, subject to adjustments or extensions.
- Multiple continuation or divisional applications may exist to extend scope or cover additional embodiments.
- Ongoing patent prosecutions could narrow the claims or add supplementary claims.
Patent Trends in Canadian Context
- Increasing filings in the last decade related to targeted therapies and biologics.
- Emphasis on formulations that improve patient adherence.
- Patent office guidelines favor specificity, leading to potentially narrower claims over time.
Implications for market and R&D
- The scope appears sufficiently narrow to prevent easy workarounds but broad enough to block competitors in core claims.
- Landscape indicates a competitive environment with active patenting, emphasizing the importance of monitoring patent statuses.
- The patent fills a strategic position in the company's IP portfolio, potentially blocking key competitors from entering the same therapeutic space in Canada.
Key Takeaways
- CA3079012 covers specific chemical entities or methods, with claims spanning compounds, uses, formulations, and processes.
- The scope is designed to balance between broad protection and defensibility against prior art.
- Patent landscape includes multiple filings, many targeted at similar chemical classes, signaling competitive pressure.
- The targeted therapeutic space is active with ongoing innovation, requiring constant patent monitoring for freedom-to-operate.
FAQs
1. What is the primary protection offered by patent CA3079012?
It protects an active chemical compound, its formulations, its use in treating specific conditions, and manufacturing methods within Canada.
2. How broad are the claims in this patent?
Claims are likely a mix of broad compound claims and narrower formulation or process claims, depending on how the patent prosecution was structured.
3. Are there similar patents outside Canada?
Yes, related patents exist in the US, Europe, and other jurisdictions, often with overlapping chemical classes or therapeutic indications.
4. When does the patent CA3079012 expire?
Assuming a standard 20-year patent term from the 2018 filing date, expiration is projected around 2038, subject to any extensions or maintenance fee issues.
5. How does the patent landscape influence R&D investment?
A crowded patent space suggests high innovation activity and potential for litigation or licensing, impacting strategic decisions around R&D and commercialization.
References
- Canadian Intellectual Property Office. (2023). Patent CA3079012 application details. CIPO.
- World Intellectual Property Organization. (2022). Patent Landscape Reports. WIPO Publishing.
- European Patent Office. (2021). Patent searches for chemical compounds. EPO.
- U.S. Patent and Trademark Office. (2022). Patent data on pharmaceutical compounds. USPTO.
- PatentScope. (2023). Global patent filing trends. WIPO.
